In lab mice, researchers found that repeated CBN exposure produced tolerance and clear withdrawal signs when the drug stopped. Those findings echo what scientists already know about some other cannabinoids: repeated use can lead the brain to adapt in ways that make it harder to stop. Translating animal results into human effects takes careful follow-up, but the mechanisms involved point to possible risks when people use these products frequently or assume they are harmless.
For anyone curious about better sleep, this raises practical questions about safety, expectation, and regulation. How should makers test products that aim to alter sleep? What does responsible use look like if an ingredient can change the brain’s response? Follow the link to read the full paper and consider how this emerging evidence connects to personal habits, product labeling, and equitable access to accurate information about sleep aids.
A cannabis-derived ingredient commonly found in sleep gummies may be more habit-forming than previously thought, with new research showing that repeated exposure caused tolerance and withdrawal symptoms in mice. Scientists warn that CBN may carry risks similar to THC, although its long-term effects in humans remain largely unknown.
